These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18842103)

  • 1. Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats.
    Lieutaud T; Andrews PJ; Rhodes JK; Williamson R
    J Neurotrauma; 2008 Oct; 25(10):1179-85. PubMed ID: 18842103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat.
    Rhodes JK; Sharkey J; Andrews PJ
    J Neurotrauma; 2009 Apr; 26(4):507-25. PubMed ID: 19210118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection by erythropoietin administration after experimental traumatic brain injury.
    Grasso G; Sfacteria A; Meli F; Fodale V; Buemi M; Iacopino DG
    Brain Res; 2007 Nov; 1182():99-105. PubMed ID: 17935704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.
    Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA
    Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of a high dose of erythropoietin-beta on early endotoxemia using a rat model.
    Eren Z; Coban J; Ekinci ID; Kaspar C; Kantarci G
    Adv Clin Exp Med; 2012; 21(3):321-9. PubMed ID: 23214195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury.
    He J; Evans CO; Hoffman SW; Oyesiku NM; Stein DG
    Exp Neurol; 2004 Oct; 189(2):404-12. PubMed ID: 15380490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats.
    Statler PA; McPherson RJ; Bauer LA; Kellert BA; Juul SE
    Pediatr Res; 2007 Jun; 61(6):671-5. PubMed ID: 17426655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin.
    Mahmood A; Lu D; Qu C; Goussev A; Zhang ZG; Lu C; Chopp M
    J Neurosurg; 2007 Aug; 107(2):392-7. PubMed ID: 17695395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures.
    Bahçekapılı N; Akgün-Dar K; Albeniz I; Kapucu A; Kandil A; Yağız O; Üzüm G
    Int J Neurosci; 2014 Oct; 124(10):762-70. PubMed ID: 24397543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma.
    Hartley CE; Varma M; Fischer JP; Riccardi R; Strauss JA; Shah S; Zhang S; Yang ZJ
    J Neurosurg; 2008 Oct; 109(4):708-14. PubMed ID: 18826359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment.
    Zhang Y; Xiong Y; Mahmood A; Meng Y; Liu Z; Qu C; Chopp M
    Brain Res; 2010 Sep; 1353():249-57. PubMed ID: 20654589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein.
    Fu A; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2010 Nov; 1360():193-7. PubMed ID: 20833153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
    Bahcekapili N; Uzüm G; Gökkusu C; Kuru A; Ziylan YZ
    Life Sci; 2007 Mar; 80(14):1245-51. PubMed ID: 17300815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Pharmacology; 2008; 82(1):38-42. PubMed ID: 18434762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM
    J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration.
    Sun Y; Calvert JW; Zhang JH
    Stroke; 2005 Aug; 36(8):1672-8. PubMed ID: 16040592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage.
    Lee ST; Chu K; Sinn DI; Jung KH; Kim EH; Kim SJ; Kim JM; Ko SY; Kim M; Roh JK
    J Neurochem; 2006 Mar; 96(6):1728-39. PubMed ID: 16539688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.